BioNTech is the Big Winner From the Vaccine Bonanza, Not Pfizer
According to the financial analyst Robert Kogon, the big winner from the Covid vaccine gold rush is not Pfizer, but BioNTech, which has made over $31…
Archive
According to the financial analyst Robert Kogon, the big winner from the Covid vaccine gold rush is not Pfizer, but BioNTech, which has made over $31…

Need an account? Register here.